Glucagon-like peptide-1 (GLP-1)
3,4 GLP-1RAs mimic the action of endogenous GLP-1, activating GLP-1R, thereby enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and reducing food intake through central appetite suppression
We prioritize patient safety and are mindful of specific considerations related to semaglutide, such as its contraindication in individuals with a history of thyroid carcinoma
Buyers who need prescription GLP-1 therapy should consult a licensed healthcare provider
After reconstitution, keep refrigerated between 2C and 8C
Many patients also notice improvements in blood sugar stability, reduced cravings for sugar, and a more even pattern of energy throughout the day